Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience;
Mamlouk, O, Selamet, U, Machado, S, Abdelrahim, M, Glass, WF, Tchakarov, A, Gaber, L, Lahoti, A, Workeneh, B, Chen, S, Lin, J, Abdel-Wahab, N, Tayar, J, Lu, H, Suarez-Almazor, M, Tannir, N, Yee, C, Diab, A & Abudayyeh, A 2019, Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, 2.

Macrophage phenotype bioengineered by magnetic, genetic, or pharmacologic interference;
Wosik, J, Suarez-Villagran, M, Miller, JH, Ghobrial, RM & Kloc, M 2019, Immunologic Research.

Coinhibition of mTORC1/mTORC2 and RhoA /ROCK pathways prevents chronic rejection of rat cardiac allografts;
Chen, W, Chen, W, Li, XC, Ghobrial, RM & Kloc, M 2018, Transplantation Reports, vol. 3, no. 4, pp. 21-28.

Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4;
Lu, N, Li, Y, Zhang, Z, Xing, J, Sun, Y, Yao, S & Chen, L 2018, Nature communications, vol. 9, no. 1, 742.

Suitability of Estimated Glomerular Filtration Rate for Live Kidney Donor Selection;
Akhimiona, CO, Nguyen, DT, Graviss, EA, Gaber, AO & Suki, WN 2018, Transplantation Proceedings, vol. 50, no. 10, pp. 3071-3075.

Transplantation for Hepatocellular carcinoma is there a tumor size limit?;
Ahmed, D, Larry, T, Mark, GR, Edward, G, Sherif, M, Amany, S, Mostafa, E-S & Osama, GA 2018, Transplantation Proceedings, vol. 50, no. 10, pp. 3577-3581.

Nanofluidic microsystem for sustained intraocular delivery of therapeutics;
Di Trani, N, Jain, P, Chua, CYX, Ho, JS, Bruno, G, Susnjar, A, Pons-Faudoa, FP, Sizovs, A, Lyle Hood, R, Smith, ZW, Ballerini, A, Filgueira, CS & Grattoni, A 2019, Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 16, pp. 1-9.

N-acetylcysteine modulation of mitochondrial respiration and blood brain barrier permeability is time depedent and cell type specific;
El Amouri, SS, Waker, C, Huang, L, Smith, C & Mayes, DA 2018, International Journal of Molecular Biology: Open Access, vol. 3, no. 6.

Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy for cancer treatment;
Chua, CYX, Filgueira, CS & Grattoni, A 2018, SITC 33rd Annual Meeting, Washington DC, United States, 11/9/18 - 11/11/18, .